AngioChem Announces Presentations at Six Upcoming Conferences
9/26/2012 9:28:02 AM
More...
|
AngioChem Named as One of the “Fierce 15” Biotech Companies of 2012
9/19/2012 9:57:08 AM
More...
|
AngioChem Presents at the 2012 Barriers of the CNS Gordon Research Conference
6/19/2012 10:12:07 AM
More...
|
AngioChem Announces Presentations at Three Upcoming Conferences
5/17/2012 10:20:24 AM
More...
|
AngioChem, GlaxoSmithKline (GSK) Form $331 Million Pact to Discover and Develop Treatments of Lysosomal Storage Diseases
2/27/2012 6:09:00 AM
More...
|
AngioChem Presents Data Demonstrating the Broad Applicability of Its EPiC Technology to Cross the Blood Brain Barrier
10/24/2011 2:07:04 PM
More...
|
AngioChem to Present at Stifel Nicolaus 2011 Healthcare Conference
9/2/2011 9:10:34 AM
More...
|
AngioChem Granted U.S. Patent for Transporting Drug Compounds across the Blood-Brain Barrier, Using Novel EPiC Technology
3/14/2011 9:22:05 AM
More...
|
AngioChem Receives Innovation Award from the National Brain Tumor Society for Advancing the Development of Novel Brain Cancer Treatments
2/15/2011 9:57:22 AM
More...
|
AngioChem Announces Plans for Advancing Product Candidates from Proprietary Platform
12/8/2010 8:46:45 AM
More...
|
|